Progyny (PGNY) Stock Price, News & Analysis

-0.66 (-2.00%)
(As of 04/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
625,184 shs
Average Volume
786,847 shs
Market Capitalization
$3.11 billion
P/E Ratio
Dividend Yield
Price Target

Progyny MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
49.1% Upside
$48.30 Price Target
Short Interest
7.87% of Float Sold Short
Dividend Strength
News Sentiment
0.50mentions of Progyny in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$4.57 M Sold Last Quarter
Proj. Earnings Growth
From $0.70 to $0.97 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.29 out of 5 stars

Medical Sector

127th out of 909 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

2nd out of 6 stocks

PGNY stock logo

About Progyny Stock (NASDAQ:PGNY)

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

PGNY Stock Price History

PGNY Stock News Headlines

He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Progyny, Inc. (PGNY)
Progyny (NASDAQ:PGNY) Rating Reiterated by Truist Financial
He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Progyny CFO sells over $419k in company stock
PGNY Apr 2024 20.000 call
PGNY Apr 2024 55.000 call
PGNY Apr 2024 30.000 call
PGNY Apr 2024 40.000 put
Truist Financial Reaffirms Their Buy Rating on Progyny (PGNY)
See More Headlines
Receive PGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Progyny and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Miscellaneous health & allied services, not elsewhere classified
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
10 Analysts


Net Income
$62.04 million
Pretax Margin


Sales & Book Value

Annual Sales
$1.09 billion
Cash Flow
$0.67 per share
Book Value
$5.77 per share


Free Float
Market Cap
$3.11 billion

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

PGNY Stock Analysis - Frequently Asked Questions

Should I buy or sell Progyny stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Progyny in the last twelve months. There are currently 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PGNY shares.
View PGNY analyst ratings
or view top-rated stocks.

What is Progyny's stock price target for 2024?

10 brokerages have issued 12 month price objectives for Progyny's shares. Their PGNY share price targets range from $43.00 to $57.00. On average, they expect the company's share price to reach $48.30 in the next year. This suggests a possible upside of 49.1% from the stock's current price.
View analysts price targets for PGNY
or view top-rated stocks among Wall Street analysts.

How have PGNY shares performed in 2024?

Progyny's stock was trading at $37.18 on January 1st, 2024. Since then, PGNY shares have decreased by 12.9% and is now trading at $32.40.
View the best growth stocks for 2024 here

When is Progyny's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our PGNY earnings forecast

How were Progyny's earnings last quarter?

Progyny, Inc. (NASDAQ:PGNY) posted its quarterly earnings results on Tuesday, February, 27th. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.04. The firm had revenue of $269.94 million for the quarter, compared to the consensus estimate of $274.08 million. Progyny had a trailing twelve-month return on equity of 12.64% and a net margin of 5.70%. Progyny's revenue for the quarter was up 26.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.03 earnings per share.

What guidance has Progyny issued on next quarter's earnings?

Progyny updated its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of 0.330-0.350 for the period, compared to the consensus EPS estimate of 0.180. The company issued revenue guidance of $285.0 million-$292.0 million, compared to the consensus revenue estimate of $314.0 million.

What is David Schlanger's approval rating as Progyny's CEO?

25 employees have rated Progyny Chief Executive Officer David Schlanger on David Schlanger has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Progyny own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Progyny investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Marvell Technology (MRVL), Alteryx (AYX), Micron Technology (MU), AbbVie (ABBV), Home Depot (HD), Advanced Micro Devices (AMD).

When did Progyny IPO?

Progyny (PGNY) raised $150 million in an IPO on Friday, October 25th 2019. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan, Goldman Sachs and BofA Merrill Lynch served as the underwriters for the IPO and Citigroup, Piper Jaffray, SVB Leerink and TPG Capital were co-managers.

Who are Progyny's major shareholders?

Progyny's stock is owned by a variety of retail and institutional investors. Top institutional investors include Congress Asset Management Co. MA (1.05%), Deepwater Asset Management LLC (0.41%), International Assets Investment Management LLC (0.16%), Congress Wealth Management LLC DE (0.16%), Rice Hall James & Associates LLC (0.08%) and Los Angeles Capital Management LLC (0.05%). Insiders that own company stock include Cheryl Scott, David J Schlanger, Group Holdings (Sbs) Advis Tpg, Jennifer Bealer, Kevin K Gordon, Mark S Livingston, Michael E Sturmer, Norman Payson, Peter Anevski, Robert Michael Floyd and Tpg Gp A, Llc.
View institutional ownership trends

How do I buy shares of Progyny?

Shares of PGNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PGNY) was last updated on 4/23/2024 by Staff

From Our Partners